Clinical Trials Directory

Trials / Completed

CompletedNCT01616511

Pathway CH-1 Long-Term Follow-Up

Long-Term Follow-Up for the Pathway CH-1 Trial: Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache

Status
Completed
Phase
Study type
Observational
Enrollment
33 (actual)
Sponsor
Autonomic Technologies, Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of the study is to demonstrate the long-term safety and performance of the ATI Neurostimulation System when used for stimulation of the sphenopalatine ganglion (SPG) in cluster headache subjects.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2012-06-11
Last updated
2017-01-09

Locations

3 sites across 3 countries: Belgium, Denmark, Spain

Source: ClinicalTrials.gov record NCT01616511. Inclusion in this directory is not an endorsement.